4//SEC Filing
Vance Holly 4
Accession 0001209191-20-055395
CIK 0001404644other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 6:15 PM ET
Size
5.7 KB
Accession
0001209191-20-055395
Insider Transaction Report
Form 4
Vance Holly
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-10-19+220,000→ 220,000 totalExercise: $12.30Exp: 2030-10-19→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total shares on October 19, 2021, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001827307
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 6:15 PM ET
- Size
- 5.7 KB